Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CX157 in Treatment Resistant Depression
NCT01246908Phase 2Completed
- Sponsor
- CeNeRx BioPharma
- Start
- Nov 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CX157 in major depressive disorder (MDD), sponsored by CeNeRx BioPharma. Started Nov 2010; status: completed.
02
Drugs
CX157
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01246908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246908.